The review found that early prophylactic mild to moderate hypothermia improved mortality and functional outcomes after severe traumatic brain injury, especially when a long-term or goal-directed cooling strategy was used. In view of limitations in the review, including poor quality studies and possible publication bias (both acknowledged by the authors), some caution may be required in interpreting the findings.
Study selection
Randomised controlled trials (RCTs) of early prophylactic mild to moderate hypothermia compared with standard management for treating adults (aged 16 years or older) with acute severe non-penetrating traumatic brain injury (Glasgow Coma Scale Score 8 or less) were eligible for inclusion. Studies were required to report mortality as an outcome. The depth of cooling in most of the included studies was 32° to 34°C (range 32° to 35°, where reported). Duration of cooling ranged from 24 hours to 14 days. Rewarming criteria varied; half of the studies did not initiate rewarming until intracranial pressure had normalised. Outcomes reported in the review were mortality, neurological outcome defined by the Glasgow Outcome Scale (GOS) and adverse events.
Papers were shortlisted by a single reviewer. Final study selection was conducted independently by two reviewers (apart from studies in Chinese, which were reviewed by a single reviewer and all five were excluded).
Assessment of study quality
Study validity was assessed by rating methods of allocation concealment and blinding of outcome assessment as adequate, unclear or inadequate. Studies where neither were adequate were rated as poor quality. It was not stated how many reviewers performed the validity assessment.
Data extraction
Neurological outcomes were dichotomised as good (GOS score 4 to 5) or poor (GOS score 1 to 3). Risk ratios (RRs) were calculated for dichotomous outcomes and mean differences for continuous outcomes, with 95% confidence intervals (CIs).
Two reviewers independently extracted data. Study authors were contacted for more information if necessary.
Methods of synthesis
Studies were combined using a random-effects model to calculate pooled risk ratios and 95% CIs. Absolute risk and number needed to treat (NNT) were calculated. Heterogeneity was assessed using Χ 2 and I 2 tests (p<0.10 and I 2 =50% signified statistical heterogeneity).
Subgroup analyses were conducted to determine the impact of length of cooling, defined as either short-term (48 hours or less) or long-term/goal-directed (over 48 hours and/or continued until intracranial pressure was normal). Sensitivity analyses were planned to determine the impact of excluding low-quality studies. Publication bias was assessed with a funnel plot.
Results of the review
Twelve RCTs were included (n=1,327, range 22 to 396). Four trials had adequate allocation concealment. Seven trials had blinded outcome assessment. Five studies were low quality. No studies blinded patients and caregivers.
Hypothermia treatment was associated with significantly lower mortality (RR 0.73, 95% CI 0.62 to 0.85, NNT=10, 95% CI 6 to 20; 12 RCTs) and greater likelihood of a good neurological outcome (RR 1.52, 95% CI 1.28 to 1.80, NNT=5, 95% CI 3 to 8; 10 RCTs) without exceeding cut-offs for statistical heterogeneity (I 2 =0% and I 2 =34%). Subgroup analysis by length of treatment, long-term or goal-directed treatment (eight RCTs) significantly improved both mortality and neurological outcomes; short-term treatment (four RCTs) did not significantly affect either outcome.
Various adverse events were reported in the intervention groups, including bradycardia (seven RCTs), hypokalaemia (six RCTs), thrombocytopaenia (four RCTs) and hypotension (three RCTs) associated with hypothermia, and rebound in intracranial pressure associated with rewarming (three RCTs of short-term cooling).
The funnel plot was suggestive of publication bias; small negative studies were less likely to be published. Sensitivity analysis by quality did not change the overall findings.
